mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.091 |
0.02 |
mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.02 |
mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.02 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.02 |
mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
-0.097 |
0.02 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.02 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.02 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.03 |